The Centers for Medicare & Medicaid Services (CMS) is now requiring long-term care facilities to report the weekly COVID-19 vaccination status of residents and staff, with the goal of monitoring vaccine uptake and identifying facilities in need of resources or assistance to respond to the pandemic.
A Phase 3 clinical trial of an antibody-drug that enrolled residents and staff at skilled nursing and assisted living facilities found that the treatment significantly reduced the risk of contracting symptomatic COVID-19.
According to the FEMA email, shipments of PPE to nursing homes will begin the first week of May on a rolling basis, and will be completed by the middle of June, NBC reported.
One of the most important weapons for fighting the novel coronavirus outbreak in the U.S. is also one of the most glaring gaps in the country’s health system: a lack of rapid, widespread testing for COVID-19.
